HC Wainwright reiterates Buy rating on ImmunityBio, sets $15 target
HC Wainwright reiterated its Buy rating and $15.00 price target on ImmunityBio. The target implies 51.4% upside from the Oct. 14 close of $9.91.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.